| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase I and pharmacokinetic study of gemcitabine given by 24-h hepatic arterial infusion
|
van Riel, J.M.
|
|
2009
|
45 |
14 |
p. 2519-2527
9 p.
|
article
|
| 2 |
Calendar
|
|
|
2009
|
45 |
14 |
p. I-
1 p.
|
article
|
| 3 |
Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I–II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected database
|
Mandalà, M.
|
|
2009
|
45 |
14 |
p. 2537-2545
9 p.
|
article
|
| 4 |
Current perspective: Bevacizumab in colorectal cancer – A time for reappraisal?
|
Okines, Alicia
|
|
2009
|
45 |
14 |
p. 2452-2461
10 p.
|
article
|
| 5 |
CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival
|
Mirisola, Valentina
|
|
2009
|
45 |
14 |
p. 2579-2587
9 p.
|
article
|
| 6 |
Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology
|
Maschmeyer, Georg
|
|
2009
|
45 |
14 |
p. 2462-2472
11 p.
|
article
|
| 7 |
Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
|
Macefield, Rhiannon C.
|
|
2009
|
45 |
14 |
p. 2569-2573
5 p.
|
article
|
| 8 |
Editorial board
|
|
|
2009
|
45 |
14 |
p. ii-
1 p.
|
article
|
| 9 |
EJC NEWS, ISSUE 14, 2009
|
|
|
2009
|
45 |
14 |
p. 2439-2443
5 p.
|
article
|
| 10 |
Estimation of an optimal chemotherapy utilisation rate for colon cancer: An evidence-based benchmark for cancer care
|
Jacob, Susannah
|
|
2009
|
45 |
14 |
p. 2503-2509
7 p.
|
article
|
| 11 |
Ethidium bromide as a vital probe of mitochondrial DNA in carcinoma cells
|
Villa, Anna Maria
|
|
2009
|
45 |
14 |
p. 2588-2597
10 p.
|
article
|
| 12 |
FASLG polymorphism is associated with cancer risk
|
Liu, Yan
|
|
2009
|
45 |
14 |
p. 2574-2578
5 p.
|
article
|
| 13 |
Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression
|
Gabellini, Chiara
|
|
2009
|
45 |
14 |
p. 2618-2627
10 p.
|
article
|
| 14 |
Health and persistent functional late effects in adult survivors of childhood CNS tumours: A population-based cohort study
|
Boman, K.K.
|
|
2009
|
45 |
14 |
p. 2552-2561
10 p.
|
article
|
| 15 |
In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma
|
Pellizzari Tregno, Francesca
|
|
2009
|
45 |
14 |
p. 2606-2617
12 p.
|
article
|
| 16 |
Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n =647) with primary breast cancer. A Danish Breast Cancer Cooperative Group Study
|
Willemoe, Gro L.
|
|
2009
|
45 |
14 |
p. 2528-2536
9 p.
|
article
|
| 17 |
Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma
|
Hundsdoerfer, Patrick
|
|
2009
|
45 |
14 |
p. 2447-2451
5 p.
|
article
|
| 18 |
Meta-analysis of genetic polymorphisms and gastric cancer risk: Variability in associations according to race
|
Loh, Marie
|
|
2009
|
45 |
14 |
p. 2562-2568
7 p.
|
article
|
| 19 |
Patients’ and health care professionals’ evaluation of health-related quality of life issues in bone metastases
|
Harris, Kristin
|
|
2009
|
45 |
14 |
p. 2510-2518
9 p.
|
article
|
| 20 |
Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: A phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5)
|
Magnusson, Marie
|
|
2009
|
45 |
14 |
p. 2488-2495
8 p.
|
article
|
| 21 |
Radiation-induced thyroid changes: A retrospective and a prospective view
|
Massimino, Maura
|
|
2009
|
45 |
14 |
p. 2546-2551
6 p.
|
article
|
| 22 |
Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial
|
Alkner, Sara
|
|
2009
|
45 |
14 |
p. 2496-2502
7 p.
|
article
|
| 23 |
Targeted therapies in the treatment of advanced/metastatic NSCLC
|
Pallis, A.G.
|
|
2009
|
45 |
14 |
p. 2473-2487
15 p.
|
article
|
| 24 |
Tissue inhibitor metalloproteinase type-1 (TIMP-1), a novel cancer biomarker predicting response of adjuvant anthracycline-based chemotherapy in patients afflicted with primary breast cancer
|
Schmitt, Manfred
|
|
2009
|
45 |
14 |
p. 2444-2446
3 p.
|
article
|
| 25 |
TRAIL-R1 polymorphisms and cancer susceptibility: An evidence-based meta-analysis
|
Chen, Bo
|
|
2009
|
45 |
14 |
p. 2598-2605
8 p.
|
article
|
Journal description